Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sherrard

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|November 15, 1979
Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysisA P Goldberg, D M Applebaum-Bowden, E L Bierman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 1, 1993
Bone disease in burn patientsG L Klein, D N Herndon, T C Rutan, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2014
Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patientsLaura J Sherrard, Bettina Schaible, Kathryn A Graham, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2002
Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysisJames W Hainer, Donald J Sherrard, Suzanne K Swan, et al.
BMC Genomics|September 1, 2018
Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centreBryan A Wee, Anna S Tai, Laura J Sherrard, et al.
Kidney International|August 18, 2005
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HClKevin J Martin, Harald Jüppner, Donald J Sherrard, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 29, 2021
Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosisLaura J Sherrard, Bryan A Wee, Christine Duplancic, et al.
Respirology (Carlton, Vic.)|March 29, 2019
Transmission of bacteria in bronchiectasis and chronic obstructive pulmonary disease: Low burden of cough aerosolsRebecca E Stockwell, Melanie Chin, Graham R Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|September 21, 2017
Face Masks and Cough Etiquette Reduce the Cough Aerosol Concentration of Pseudomonas aeruginosa in People with Cystic FibrosisMichelle E Wood, Rebecca E Stockwell, Graham R Johnson, et al.
Kidney International|January 28, 2005
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HClSharon M Moe, Glenn M Chertow, Jack W Coburn, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|November 15, 1979
Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysisA P Goldberg, D M Applebaum-Bowden, E L Bierman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 1, 1993
Bone disease in burn patientsG L Klein, D N Herndon, T C Rutan, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2014
Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patientsLaura J Sherrard, Bettina Schaible, Kathryn A Graham, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2002
Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysisJames W Hainer, Donald J Sherrard, Suzanne K Swan, et al.
BMC Genomics|September 1, 2018
Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centreBryan A Wee, Anna S Tai, Laura J Sherrard, et al.
Kidney International|August 18, 2005
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HClKevin J Martin, Harald Jüppner, Donald J Sherrard, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 29, 2021
Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosisLaura J Sherrard, Bryan A Wee, Christine Duplancic, et al.
Respirology (Carlton, Vic.)|March 29, 2019
Transmission of bacteria in bronchiectasis and chronic obstructive pulmonary disease: Low burden of cough aerosolsRebecca E Stockwell, Melanie Chin, Graham R Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|September 21, 2017
Face Masks and Cough Etiquette Reduce the Cough Aerosol Concentration of Pseudomonas aeruginosa in People with Cystic FibrosisMichelle E Wood, Rebecca E Stockwell, Graham R Johnson, et al.
Kidney International|January 28, 2005
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HClSharon M Moe, Glenn M Chertow, Jack W Coburn, et al.
Pageof 16